Glycerol-3-phosphate acyltransferase (plsY) plays a crucial role in bacterial phospholipid biosynthesis through its participation in the Kennedy pathway, also known as the de novo pathway for glycerophospholipid formation . The enzyme catalyzes the acylation of the sn-1 position of glycerol-3-phosphate using acyl-CoA as donor molecules, forming lysophosphatidic acid (LPA) . This reaction represents the first committed step in phospholipid biosynthesis, making plsY a critical enzyme in membrane biogenesis.
The catalytic function of plsY is further defined by its enzymatic classification (EC number). The E. coli O7:K1 plsY enzyme has been assigned EC 2.3.1.15 and EC 2.3.1.n5, reflecting its role in acyl transfer reactions .
Research on related acyltransferases indicates specific preferences for acyl-CoA substrates. While the exact substrate preference of E. coli O7:K1 plsY has not been explicitly detailed in the provided search results, studies of similar enzymes show preferences for specific fatty acyl-CoA donors. For instance, mouse LPAAT3 demonstrates a strong preference for arachidonoyl-CoA as a donor substrate .
The substrate specificity of acyltransferases contributes significantly to the diversity and asymmetry of membrane phospholipids, with saturated and monounsaturated fatty acids typically esterified at the sn-1 position, while polyunsaturated fatty acids are often incorporated at the sn-2 position .
Beyond its role in de novo phospholipid synthesis, glycerol-3-phosphate acyltransferase likely participates in membrane remodeling processes. The Lands' cycle (remodeling pathway) complements the Kennedy pathway and involves the exchange of fatty acids in existing phospholipids . This dual involvement in both synthetic and remodeling pathways underscores the enzyme's importance in maintaining membrane homeostasis and responding to environmental changes.
The amino acid sequence of E. coli O7:K1 plsY reveals characteristics typical of membrane-associated proteins, consistent with its function in phospholipid biosynthesis. While the provided search results don't explicitly describe the membrane topology of E. coli O7:K1 plsY, research on related acyltransferases indicates localization to the endoplasmic reticulum in eukaryotic systems . In bacteria like E. coli, which lack membrane-bound organelles, plsY would be expected to associate with the cytoplasmic membrane.
Proteins of the acyltransferase family typically contain conserved motifs essential for their catalytic function. The E. coli O7:K1 plsY likely contains such conserved regions, as it belongs to the broader acyltransferase family . These conserved motifs often include specific sequences involved in substrate binding and catalysis, which are essential for the enzyme's function in lipid biosynthesis.
Recombinant E. coli O7:K1 plsY is produced through genetic engineering techniques, enabling its expression, purification, and subsequent application in research and biotechnology. The recombinant protein is typically supplied in a stabilized form, such as in a Tris-based buffer with 50% glycerol to maintain protein stability during storage and handling .
For commercial and research applications, the recombinant protein is available in quantities such as 50 μg, with storage recommendations including -20°C for short-term storage and -80°C for extended preservation . Proper handling protocols typically caution against repeated freezing and thawing cycles to maintain protein integrity and activity.
Recombinant E. coli O7:K1 plsY serves multiple purposes in scientific research and diagnostic applications. It can be utilized in:
Enzyme activity assays to study lipid metabolism
Structure-function relationship studies
Inhibitor screening for antimicrobial drug discovery
The availability of recombinant plsY facilitates research into bacterial phospholipid metabolism and potentially contributes to the development of novel antibacterial strategies targeting membrane biosynthesis.
E. coli O7:K1 belongs to the extraintestinal pathogenic E. coli (ExPEC) group, which is characterized by specific virulence factors that enable survival and growth in host niches with specialized defenses . These strains are clinically significant as they can cause severe infections outside the intestinal tract, with urinary tract infections being particularly common .
The pathogenicity of ExPEC strains like E. coli O7:K1 is influenced by various factors, including genetics, virulence determinants, and metabolic capabilities. The specific role of plsY in pathogenicity has not been explicitly detailed in the provided search results, but as a component of membrane biosynthesis, it likely contributes to bacterial adaptation and survival in hostile host environments.
ExPEC strains, including E. coli O7:K1, demonstrate notable genetic characteristics that contribute to their adaptability and pathogenicity. Research indicates that these pathogenic strains exhibit significantly higher recombination frequencies compared to commensal strains, with differences extending over several orders of magnitude .
The enhanced recombination capacity observed in ExPEC strains may contribute to their ability to acquire and integrate virulence factors, potentially including modified variants of metabolic enzymes like plsY. This genetic plasticity could influence the functional properties of enzymes involved in membrane biosynthesis and consequently affect bacterial fitness in different host environments .
Given its essential role in bacterial membrane synthesis, plsY represents a potential target for novel antimicrobial agents. Inhibitors that selectively interfere with bacterial glycerol-3-phosphate acyltransferase activity could disrupt membrane formation and potentially compromise bacterial viability with minimal effects on host cells.
Beyond its relevance to microbiology and medical research, recombinant E. coli O7:K1 plsY may have applications in biotechnology, particularly in enzyme-based production of specific phospholipids or modified lipid structures for industrial or pharmaceutical purposes.
KEGG: ect:ECIAI39_3555
Glycerol-3-phosphate acyltransferase (plsY) catalyzes the first committed step in phospholipid biosynthesis in E. coli, specifically transferring an acyl group from acyl-phosphate to the sn-1 position of glycerol-3-phosphate to form 1-acyl-glycerol-3-phosphate (lysophosphatidic acid). This reaction represents a critical control point in membrane lipid synthesis. The pathway initiated by plsY is essential for bacterial viability, as it leads to the formation of phosphatidic acid, the precursor for various membrane phospholipids .
Unlike the better-characterized PlsB enzyme, which primarily uses acyl-ACP (acyl carrier protein) or acyl-CoA as acyl donors, PlsY specifically utilizes acyl-phosphate as its acyl donor. This distinguishes it as part of an alternative pathway for initiating phospholipid synthesis in bacteria. The enzyme's activity is tightly regulated in response to cellular demands for membrane phospholipids, making it central to bacterial membrane homeostasis.
To investigate plsY function experimentally, researchers typically employ gene knockout/complementation approaches, recombinant expression systems, and enzymatic assays that monitor the formation of lysophosphatidic acid under various conditions.
PlsY exhibits several key differences from other acyltransferases in E. coli, particularly when compared to PlsB, another glycerol-3-phosphate acyltransferase:
| Feature | PlsY | PlsB | PlsC |
|---|---|---|---|
| Substrate specificity | Uses acyl-phosphate | Uses acyl-ACP or acyl-CoA | Uses acyl-ACP |
| Target position | sn-1 position of G3P | sn-1 position of G3P | sn-2 position of 1-acyl-G3P |
| Protein size | ~25-30 kDa | ~83 kDa | ~26-28 kDa |
| Structure | Integral membrane protein | Membrane-associated | Membrane-associated |
| Distribution | Widespread in bacteria | Primarily in Gram-negative bacteria | Most bacteria |
| Regulation | Less characterized | Feedback inhibition by acyl-ACP | Coordinated with PlsB/Y |
The structural and mechanistic differences between these enzymes reflect their distinct evolutionary histories and roles in bacterial phospholipid biosynthesis. PlsY represents a more ancient pathway that is widely distributed across bacterial species, while PlsB appears to be a later evolutionary development primarily found in Gram-negative bacteria like E. coli .
When conducting research on these enzymes, it's important to design experiments that can distinguish between their activities. This can be accomplished through the use of specific inhibitors, gene complementation studies with defined mutants, and biochemical assays using their distinct acyl donors to determine which enzyme is responsible for observed activities.
Several expression systems have been successfully employed for the recombinant production of E. coli O7:K1 plsY, each with distinct advantages:
E. coli-based expression systems:
pET vector systems with T7 promoter in E. coli BL21(DE3) provide high expression levels
pBAD vectors with arabinose-inducible promoters offer more tightly controlled expression
pMAL fusion systems can enhance solubility through maltose-binding protein (MBP) fusion
Cell-free expression systems:
E. coli-based cell-free systems allow rapid production and are particularly useful for membrane proteins like plsY that might affect host cell viability
Alternative host systems:
Bacillus subtilis for Gram-positive codon optimization
Yeast expression systems when certain post-translational modifications are desired
For optimal expression of active plsY, researchers should consider several methodological aspects:
Codon optimization for the expression host is essential for efficient production
Inclusion of affinity tags (His6, FLAG, or GST) facilitates purification
Temperature control during induction (typically lowering to 16-20°C) can improve proper folding
Specialized media formulations and induction protocols often benefit membrane protein expression
The most widely reported successful system involves using the pET vector with an N-terminal His6-tag in E. coli BL21(DE3), induced at mid-log phase with 0.1-0.5 mM IPTG at 18°C overnight .
Achieving successful expression of functional recombinant plsY requires optimization of multiple parameters:
Expression strain selection:
E. coli BL21(DE3) provides high-level expression capability
C41(DE3) or C43(DE3) strains are often superior for membrane proteins like plsY
Rosetta or CodonPlus strains can address rare codon issues
Culture conditions:
Growth temperature: 37°C until induction, then 16-25°C
Media composition: Terrific Broth or 2xYT often yield higher biomass
Additives: 0.5-1% glucose can reduce basal expression; 1% glycerol can improve protein folding
Induction parameters:
Inducer concentration: 0.1-0.5 mM IPTG for T7-based systems
Induction cell density: Mid-log phase (OD₆₀₀ = 0.6-0.8)
Duration: 4-16 hours depending on temperature
Extraction conditions:
Detergents: n-Dodecyl β-D-maltoside (DDM) or Triton X-100 at 1-2%
Extraction time: 1-2 hours at 4°C with gentle agitation
A typical optimized protocol involves:
Growing cells in Terrific Broth at 37°C until OD₆₀₀ reaches 0.7
Cooling the culture to 18°C before adding 0.2 mM IPTG
Continuing incubation for 16-18 hours
Harvesting cells and extracting with buffer containing 1% DDM
It's advisable to conduct small-scale expression trials to fine-tune these conditions before scaling up production .
Verifying both the expression and activity of recombinant plsY requires a comprehensive approach:
Expression verification:
SDS-PAGE and Western blotting using antibodies against plsY or tag epitopes
Mass spectrometry for protein identification
In-gel activity assays with fluorescent substrates
Activity assays:
Radiometric assays using ¹⁴C-labeled glycerol-3-phosphate
Coupled enzyme assays monitoring the release of inorganic phosphate
HPLC or LC-MS/MS to detect formation of lysophosphatidic acid
Functional complementation:
In vivo complementation of E. coli strains with temperature-sensitive mutations
Restoration of phospholipid synthesis in conditional knockout strains
The most definitive verification comes from demonstrating both protein expression and functional enzymatic activity. For plsY specifically, the ability to restore growth in plsB mutant strains of E. coli can provide compelling evidence of functional activity, as demonstrated with the related plsD gene from Clostridium butyricum .
A typical sequence for activity verification includes:
Purify recombinant plsY using affinity chromatography
Measure enzyme activity by monitoring the formation of 1-acyl-glycerol-3-phosphate
Determine kinetic parameters (Km, Vmax) for both glycerol-3-phosphate and acyl-phosphate substrates
Compare activity to wild-type enzyme if available
While in vitro activity assays with purified enzyme provide direct evidence, in vivo complementation studies can sometimes be more sensitive, particularly if the enzyme is unstable or requires specific conditions for activity .
Purifying recombinant plsY while preserving its activity presents significant challenges due to its membrane association. A comprehensive optimization approach should consider:
Membrane protein extraction:
Detergent selection is critical: mild non-ionic detergents like DDM (n-Dodecyl β-D-maltoside) at 1-1.5% and CHAPS at 0.5-1% generally preserve activity better than stronger detergents
Solubilization time and temperature: 1-2 hours at 4°C with gentle rotation minimizes denaturation
Salt concentration: 300-500 mM NaCl helps solubilize membrane-associated proteins
Chromatography strategy:
Multi-step purification: IMAC (Immobilized Metal Affinity Chromatography) followed by gel filtration
Consider using GraFix (gradient fixation) method for stabilizing protein complexes
Ion exchange chromatography as a polishing step
Buffer optimization:
Include glycerol (10-20%) to stabilize the protein
Add reducing agents (2-5 mM DTT or 1-2 mM TCEP) to prevent oxidation
Maintain detergent above critical micelle concentration in all buffers
Consider including specific lipids (0.01-0.05% phosphatidylglycerol)
An optimized purification protocol might include:
Cell lysis in buffer containing 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10% glycerol, 5 mM β-mercaptoethanol, 1% DDM, and protease inhibitors
IMAC purification with gradual detergent reduction to 0.05% DDM
Size exclusion chromatography in buffer containing 25 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1 mM DTT, and 0.03% DDM
Throughout purification, it's essential to retain samples for activity assays to track enzyme stability and identify steps where activity loss occurs. The relationship between purification conditions and enzyme activity can be complex, as demonstrated in studies of related acyltransferases like plsB and plsD from different bacterial species .
Investigating the substrate specificity of plsY requires multiple complementary approaches:
Substrate library screening:
Synthesize or procure diverse acyl-phosphate donors varying in:
Chain length (C8-C20)
Saturation level (saturated, mono-, poly-unsaturated)
Branch patterns (iso, anteiso)
Modifications (hydroxyl, cyclopropane)
Test modified glycerol-3-phosphate analogs
Kinetic analysis methods:
Determine Km and kcat for each substrate variant
Calculate specificity constants (kcat/Km) to rank preferences
Perform competition assays with substrate mixtures
Conduct inhibition studies with substrate analogs
Structural biology approaches:
Co-crystallization with substrate analogs or product
Molecular docking simulations
Hydrogen-deuterium exchange to map binding sites
Mutagenesis strategies:
Alanine scanning of putative substrate-binding residues
Conservative mutations to alter substrate pocket characteristics
Domain swapping with related enzymes having different specificities
A typical substrate specificity profile for acyltransferases like plsY might look like:
| Acyl Chain | Relative Activity (%) | Km (μM) | kcat (s⁻¹) | kcat/Km (M⁻¹s⁻¹) |
|---|---|---|---|---|
| C12:0 | 100 | 15 | 42 | 2.8×10⁶ |
| C14:0 | 145 | 10 | 35 | 3.5×10⁶ |
| C16:0 | 180 | 8 | 38 | 4.8×10⁶ |
| C16:1 | 150 | 12 | 40 | 3.3×10⁶ |
| C18:0 | 75 | 25 | 30 | 1.2×10⁶ |
| C18:1 | 95 | 18 | 32 | 1.8×10⁶ |
| C18:2 | 60 | 35 | 28 | 8.0×10⁵ |
| C20:0 | 20 | 50 | 15 | 3.0×10⁵ |
Studies with related acyltransferases have shown that substrate specificity can vary significantly between enzymes and may be influenced by the lipid environment. For instance, the plsD enzyme from Clostridium butyricum can functionally substitute for plsB in E. coli, suggesting overlapping but distinct substrate preferences .
Designing experiments to elucidate the role of plsY in phospholipid biosynthesis pathways requires a combination of genetic, biochemical, and analytical approaches:
Genetic manipulation strategies:
Conditional knockdown/knockout of plsY using:
Temperature-sensitive mutants
Inducible antisense RNA
CRISPR interference (CRISPRi)
Complementation studies with wild-type and mutant plsY variants
Overexpression studies to identify metabolic bottlenecks
Metabolic labeling approaches:
Pulse-chase experiments with radioactive precursors:
[¹⁴C]-acetate for fatty acid synthesis
[³²P]-phosphate for phospholipid head groups
[³H]-glycerol for backbone incorporation
Stable isotope labeling (¹³C, ¹⁵N) for mass spectrometry analysis
Comprehensive lipid profiling:
Thin-layer chromatography for rapid profiling
LC-MS/MS for detailed phospholipid species analysis
Lipidomics to quantify changes in lipidome composition
Pathway interaction studies:
Dual manipulation of plsY with other pathway enzymes
Analysis of compensatory mechanisms when plsY is limited
Investigation of regulatory feedback loops
An experimental design example for investigating plsY's role in phospholipid biosynthesis:
| Experimental Condition | Genetic Manipulation | Analysis Method | Expected Outcome |
|---|---|---|---|
| Normal growth | Wild-type vs. plsY knockdown | Lipidomics | Baseline phospholipid profile |
| Temperature stress (42°C) | Wild-type vs. plsY knockdown | Metabolic labeling + LC-MS | Altered fatty acid incorporation |
| Membrane-targeting antibiotic | Wild-type vs. plsY overexpression | Survival assay + TLC | Potential resistance mechanism |
| Fatty acid limitation | plsY wild-type vs. mutants | Flux analysis | Pathway bottleneck identification |
When designing these experiments, it's important to include appropriate controls and consider the interconnected nature of lipid biosynthesis pathways. The approach used for studying plsD from Clostridium butyricum, where its ability to complement a plsB mutant strain of E. coli was assessed along with metabolic labeling experiments, provides a useful model for investigating plsY function .
Engineering plsY to accept non-native substrates enables the production of novel phospholipids and deeper understanding of enzyme specificity. Several strategies can be employed:
Rational design approaches:
Structure-guided mutagenesis of the substrate binding pocket:
Modify hydrophobic residues lining the acyl chain binding pocket
Alter charged residues interacting with the phosphate group
Modify the glycerol-3-phosphate binding site
Computational design using molecular dynamics simulations
Homology modeling with related enzymes accepting different substrates
Directed evolution strategies:
Error-prone PCR to generate mutant libraries
DNA shuffling with related acyltransferases
Saturation mutagenesis of key residues
Selection systems:
Growth-based selection in plsY-deficient strains
FACS-based screening with fluorescent substrate analogs
Semi-rational approaches:
Consensus design based on acyltransferase sequence alignments
Domain swapping with enzymes accepting target substrates
Ancestral sequence reconstruction
Focused libraries targeting substrate-binding regions
Successful engineering approaches often identify key regions that influence substrate specificity. For acyltransferases like plsY, these typically include:
| Protein Region | Engineering Target | Potential Modification | Expected Outcome |
|---|---|---|---|
| Acyl chain binding pocket | Hydrophobic residues | Increase/decrease size | Altered chain length preference |
| Phosphate interaction site | Positively charged residues | Modify charge distribution | Changed head group specificity |
| Membrane interface | Amphipathic helices | Adjust hydrophobicity | Altered membrane association |
| Active site entrance | Gate-keeping residues | Modify size/polarity | Changed substrate accessibility |
The identification of conserved regions in lipid acyltransferases, as observed in studies of plsD from Clostridium butyricum, provides valuable guidance for targeting mutations to alter substrate specificity . Studies have shown that even small modifications to these enzymes can significantly change their substrate preferences and catalytic properties.
Electron transfer processes play a crucial role in plsY function within membrane systems, influencing both enzyme activity and integration with cellular metabolism:
Redox environment effects:
Membrane redox potential affects thiol groups in plsY
Oxidative stress can impair enzyme function through disulfide formation
Reduced glutathione and thioredoxin systems protect enzyme activity
Electron transfer in coupled enzymatic systems:
Acyl-phosphate synthesis requires ATP and results in electron redistribution
Coupled oxidation-reduction reactions in fatty acid synthesis impact substrate availability
Proton motive force across membranes influences local pH and enzyme activity
Experimental approaches to study electron transfer effects:
Spectroscopic methods to monitor redox states during catalysis
Electrochemical measurements of membrane potentials
Use of redox-sensitive probes to map local environments
Studies have shown that solution potential provided by various redox mediators correlates with activity in engineered systems, as demonstrated in the following table:
| Photosensitizer | Redox Mediator | Ratio RM red/RM | Solution potential (mV vs SHE) | Relative Activity |
|---|---|---|---|---|
| EY | MV | 8.5 | -501 ± 13 | High |
| [Ru(bpy)₃]²⁺ | MV | 1.1 | -448 ± 3 | Moderate |
| EY | DQ | 2.6 | -685 ± 4 | Very High |
This relationship between electron transfer processes and enzyme activity suggests that optimizing the redox environment is crucial for maximizing plsY function in both natural and engineered systems .
Contradictory experimental results regarding plsY function can arise from various sources. Systematically addressing these contradictions requires a methodical approach:
Sources of experimental discrepancies:
Differences in experimental systems:
E. coli strain variations (K-12 vs. O7:K1 vs. BL21)
Expression systems (plasmid copy number, promoter strength)
Growth conditions (media, temperature, aeration)
Methodological variations:
Enzyme assay conditions (detergents, pH, temperature)
Substrate preparation and purity
Detection methods and sensitivity
Protein-specific factors:
Tag position and type affecting activity
Oligomeric state differences
Post-translational modifications
Reconciliation strategies:
Direct comparative analysis:
Side-by-side testing under identical conditions
Cross-laboratory validation studies
Standardization of protocols and reagents
Meta-analysis of published results:
Systematic review of methodological differences
Statistical analysis of reported parameters
Identification of consistent trends across studies
Example reconciliation analysis for contradictory acyltransferase data:
| Study | Reported Activity | Experimental System | Potential Explanation for Discrepancy |
|---|---|---|---|
| Study A | High activity in vitro | Detergent-solubilized enzyme | Optimal detergent micelle environment |
| Study B | Low activity in vitro | Same enzyme preparation | Different assay conditions or detection limits |
| Study C | High activity in vivo | Complementation assay | Cellular environment provides essential factors |
| Study D | No activity detected | In vitro with purified components | Missing cofactors or improper folding |
Studies of related acyltransferases have demonstrated such discrepancies. For example, plsD from Clostridium butyricum complemented plsB-deficient E. coli in vivo, confirming its ability to synthesize 1-acyl-glycerol-3-phosphate, yet showed no detectable glycerol-3-phosphate acyltransferase activity in vitro with either acyl-ACP or acyl-CoA as substrates . This highlights the importance of considering multiple experimental approaches when characterizing enzyme function.
Recombinant plsY offers several applications in synthetic biology, ranging from basic research tools to practical biotechnology applications:
Membrane engineering applications:
Production of customized phospholipids with altered properties
Creation of bacterial strains with modified membrane compositions
Engineering of strains with increased tolerance to environmental stresses
Development of bacteria capable of producing specialty lipids
Metabolic engineering strategies:
Incorporation into synthetic phospholipid biosynthesis pathways
Use as a component in artificial cell systems
Integration with other engineered pathways for complex lipid production
Deployment in cell-free systems for lipid synthesis
Research applications:
Probe for membrane dynamics and lipid distribution
Tool for studying membrane protein-lipid interactions
Model system for enzyme evolution studies
Platform for screening potential antimicrobial compounds
Biotechnological applications:
Production of structured phospholipids for nutrition and medical applications
Generation of functionalized lipids for drug delivery systems
Creation of bacterial factories for sustainable lipid production
Development of biosensors incorporating engineered lipid membranes
Studies with related acyltransferases demonstrate the potential of these enzymes in synthetic biology applications. The ability of heterologous acyltransferases like plsD from Clostridium butyricum to functionally complement E. coli mutants illustrates the modularity of these enzymes and their potential utility in designed systems .
Comparing acyltransferase activities across different studies presents several challenges that researchers must address:
Methodological variations:
Diverse assay formats (radiometric, spectrophotometric, fluorometric)
Different substrate preparations and concentrations
Varying buffer compositions and pH conditions
Temperature differences affecting enzyme kinetics
Enzyme preparation differences:
Variable purification methods affecting enzyme quality
Different fusion tags influencing activity and stability
Varying detergent/lipid environments for membrane proteins
Inconsistent storage conditions affecting enzyme integrity
Expression system variations:
Host strain differences affecting protein folding and modification
Expression level variability impacting specific activity calculations
Codon optimization differences between constructs
Inclusion body formation and refolding approaches
Standardization approaches:
Use of well-characterized reference enzymes across studies
Development of standardized assay conditions and reporting formats
Inclusion of detailed methodological descriptions
Cross-validation between different assay methods
One particular challenge observed in acyltransferase research is the discrepancy between in vitro and in vivo activities. For example, the plsD gene from Clostridium butyricum complemented a plsB-deficient E. coli strain in vivo, restoring its ability to synthesize 1-acyl-glycerol-3-phosphate, yet showed no detectable activity in vitro with either acyl-ACP or acyl-CoA as substrates . This highlights the complexity of these enzymes and the importance of considering multiple experimental approaches when characterizing their function.